Effect of modafinil on cerebral blood flow in narcolepsy patients

Sleep

Volumn 31, Issue 6, 2008, Pages 868-873

  Joo, Eun Yeon ^a   Seo, Dae Won ^a   Tae, Woo Suk ^a   Hong, Seung Bong ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Modafinil; Narcolepsy; rCBF; SPECT; Statistical parametric mapping

Indexed keywords

ETHYLCYSTEINATE TC 99M; MODAFINIL; PLACEBO; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; ARTICLE; BRAIN BLOOD FLOW; CATAPLEXY; CEREBELLUM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DOSE REDUCTION; EPWORTH SLEEPINESS SCALE; FEMALE; FRONTAL CORTEX; HAND TREMOR; HEADACHE; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; KERNEL METHOD; MALE; NARCOLEPSY; NERVOUSNESS; NEUROIMAGING; PRIORITY JOURNAL; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STUDENT T TEST;

EID: 44949221439     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/31.6.868     Document Type: Article

References (33)

1. American Academy of Sleep Medicine. The international classification of sleep disorders: diagnostic & coding manual, 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005.
2. Bastuji H, Jouvet M. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuropsychopharmacol Biol Psychiatry 1988;12:695-700.
3. U.S. Modafinil in narcolepsy multicenter study group: Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 1998;43:88-97.
4. Duteil J, Rambert FA, Pessonnier J, Hermant JF, Gombert R, Assous E. Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur J Pharmacol 1990;180:49-58.
5. Ferraro L, Tanganelli S, O'Connor WT, Antonelli T, Rambert F, Fuxe K. The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor. Neurosci Lett 1996;220:5-8.
6. Tanganelli S, Ferraro L, Bianchi C, Fuxe K. 6-hydroxy-dopamine treatment counteracts the reduction of cortical GABA release produced by the vigilance promoting drug modafinil in the awake freely moving guinea-pig. Neurosci Lett 1994;171:201-4.
7. Tanganelli S, Perez de la Mora M, Ferraro L, et al. Modafinil and cortical gamma-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins. Eur J Pharmacol 1995;273:63-71.
8. Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001;21:1787-94.
9. Scammell TE, Estabrooke IV, McCarthy MT, et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000;22:8620-8.
10. Tanganelli S, Fuxe K, Ferraro L, Janson AM, Bianchi C. Inhibitory effects of the psychoactive drug modafinil on gamma-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig. Possible involvement of 5-hydroxytryptamine mechanisms. Naunyn Schmiedeberg Arch Pharmacol 1992;345:461-5.
11. Rechtshaffen A, Kales A. eds. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. UCLA, Brain Information Service/Brain Research Institute, Los Angeles; 1968.
12. Chang L. A method for attenuation correction in computed tomography. IEEE Trans Nucl Sci 1987;NS-25:638-43.
13. Joo EY, Tae WS, Kim JH, Kim BT, Hong SB. Glucose hypometabolism of hypothalamus and thalamus in narcolepsy. Ann Neurol 2004;56:437-40.
14. Joo EY, Hong SB, Tae WS, et al. Cerebral perfusion abnormality in narcolepsy with cataplexy. Neuroimage 2005;28:410-6.
15. Spencer JS, Carmack PS, Gunst RF, Schucany WR, Woodward WA, Haley RW. Using a white matter reference to remove the dependency of global signal on experimental conditions in SPECT analyses. Neuroimage 2006;32:49-53.
16. Hunter MD, Ganesan V, Wilkinson ID, Spence SA. Impact of modafinil on prefrontal executive function in schizophrenia. Am J Psychiatry 2006;163:2184-6.
17. Friston KJ, Holmes A, Poline JB, Price CJ, Frith CD. Detecting activations in PET and fMRI: levels of inference and power. Neuroimage 1996;4:223-35.
18. Dang-Vu TT, Desseilles M, Laureys S, et al. Cerebral correlates of delta waves during non-REM sleep revisited. Neuroimage 2005;28:14-21.
19. Maquet P, Ruby P, Maudoux A, et al. Human cognition during REM sleep and the activity profile within frontal and parietal cortices: a reappraisal of functional neuroimaging data. Prog Brain Res 2005;150:219-27.
20. Hobson JA, Pace-Schott EF, Stickgold R, Kahn D. To dream or not to dream? Relevant data from new neuroimaging and electrophysiological studies. Curr Opin Neurobiol 1998;8:239-44.
21. Maquet P, Degueldre C, Delfiore G, et al. Functional neuroanatomy of human slow wave sleep. J Neurosci 1997;17:2807-12.
22. Maquet P. Functional neuroimaging of normal human sleep by positron emission tomography. J Sleep Res 2000;9:207-31.
23. Peterson BS, Skudlarski P, Gatenby JC, Zhang H, Anderson AW, Gore JC. An fMRI study of Stroop word-color interference: evidence for cingulate subregions subserving multiple distributed attentional systems. Biol Psychiatry 1999;45:1237-58.
24. Ungerleider LG, Courtney SM, Haxby JV. A neural system for human visual working memory. Proc Natl Acad Sci U S A 1998;95:883-90.
25. Broughton R, Ghanam Q, Hishikawa Y, Sugita Y, Nevsimalova S, Roth B. Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls. Can J Neurol Sci 1981;8:199-204.
26. Henry GK, Satz P, Heilbronner RL. Evidence of perceptual encoding deficit in narcolepsy. Sleep 1993;16:123-7.
27. Aguirre M, Broughton R, Stuss D. Does memory impairment exist in narcolepsy-cataplexy. J Clin Exp Neuropsychol 1985;7:14-24.
28. Fulda S, Schulz H. Cognitive dysfunction in sleep disorders. Sleep Med Rev 2001;5: 423-45.
29. Porter BE, Zhang G, Celix J, et al. Heterogeneous GABAA receptor subunit expression in pediatric epilepsy patients. Neurobiol Dis 2005;18:484-91.
30. Van Laere K, Versijpt J, Audenaert K, et al. 99mTc-ECD brain perfusion SPET: variability, asymmetry and effects of age and gender in healthy adults. Eur J Nucl Med 2001;28:873-87.
31. Van Vliet SA, Vanwersch RA, Jongsma MJ, van der Gugten J, Olivier B, Philippens TH. Neuroprotective effects of modafinil in a marmoset Parkinson model: behavioral and neurochemical aspects. Behav Pharmacol 2006;17:435-62.
32. Fuxe K, Rambert FA, Ferraro L, et al. Preclinical studies with modafinil-evidence for vigilance enhancement and neuroprotection. Drugs Today 1996;32:313-26.
33. Lin JS, Hou Y, Jouvet M. Potential brain neuronal targets for amphetamine methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci U S A 1996;93:14128-33.